Free Account Opening + AMC Free Demat
Loading...

Avon Weighing IPO vs Bafna Pharmaceuticals IPO

Comparision between Avon Weighing IPO and Bafna Pharmaceuticals IPO.

IPO Details

Avon Weighing IPO is a Mainline Fixed Price Issue IPO proposed to list at BSE while Bafna Pharmaceuticals IPO is a Mainline Fixed Price Issue proposed to list at BSE.

  Avon Weighing IPO Bafna Pharmaceuticals IPO
Logo Avon Weighing IPO Logo Bafna Pharmaceuticals IPO Logo
Issue Category Mainline Mainline
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At BSE BSE
Lead Managers Keynote Financial Services Ltd Keynote Financial Services Ltd

Ashika Capital Ltd
Registrar Datamatics Financial Services Ltd Cameo Corporate Services Limited
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Avon Weighing IPO is up to ₹9.84 Cr whereas the issue size of the Bafna Pharmaceuticals IPO is up to ₹25.60 Cr. The final issue price of Avon Weighing IPO is ₹10.00 per share and of Bafna Pharmaceuticals IPO is ₹40.00 per share.

  Avon Weighing IPO Bafna Pharmaceuticals IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹10.00 per share ₹40.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 98,36,400 shares 64,00,000 shares
Issue Size Total (Amount) up to ₹9.84 Cr up to ₹25.60 Cr

IPO Timetable

Avon Weighing IPO opens on Jun 09, 2008, while Bafna Pharmaceuticals IPO opens on May 27, 2008. The closing date of Avon Weighing IPO and Bafna Pharmaceuticals IPO is Jun 12, 2008, and May 30, 2008, respectively.

  Avon Weighing IPO Bafna Pharmaceuticals IPO
Anchor Bid Date
Issue Open Jun 09, 2008 May 27, 2008
Issue Close Jun 12, 2008 May 30, 2008
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Avon Weighing IPO P/E ratio is , as compared to Bafna Pharmaceuticals IPO P/E ratio of .

  Avon Weighing IPO Bafna Pharmaceuticals IPO
Financial
ParticularsFor the year/period ended (Rs. in lacs)
  31-Mar-0731-Mar-0631-Mar-0531-Mar-0431-Mar-03
  Total Income4017.452422.771171.22823.98699.43
  Profit After Tax (PAT)137.4689.3033.2315.6812.32
ParticularsFor the year/period ended (Rs. in lacs)
 30-Jun-0731-Mar-0731-Mar-0631-Mar-0531-Mar-04
  Total Income432.023861.962136.472662.651521.33
  Profit After Tax (PAT)49.70104.2392.2789.8144.51
Promoter Shareholding (Pre-Issue) 100% 71.07%
Promoter Shareholding (Post-Issue) 40.67% 42.6%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW 31.93%% 10.65%%

Shares Offered

In the Avon Weighing IPO retail investors (RII) are offered while in Bafna Pharmaceuticals IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Avon Weighing IPO and in Bafna Pharmaceuticals IPO.

  Avon Weighing IPO Bafna Pharmaceuticals IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB
NII
RII
Employee
Others
Total

Bids Received (Subscription)

Avon Weighing IPO subscribed in total, whereas Bafna Pharmaceuticals IPO subscribed .

  Avon Weighing IPO Bafna Pharmaceuticals IPO
QIB (times)
NII (times)
Big NII (times)
Small NII (times)
RII (times)
Employee (times)
Other (times)
Total (times)

Comments

Add a public comment...